United States· US:63083-7408_bb27263d-6dbc-4fc5-90ac-0baa5bacac2d
L-Glycine High
A medicinal product containing hexapeptide-12 (val-gly-val-ala-pro-gly), registered in United States by Professional Complementary Health Formulas.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HEXAPEPTIDE-12 (VAL-GLY-VAL-ALA-PRO-GLY)
- Manufacturer
- Professional Complementary Health Formulas
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11630837408259 mL in 1 BOTTLE, DROPPER (63083-7408-2)
- ndc1163083-7408-2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d1fb02dc-ab6d-4af0-9807-3c6f4dbae1b4 GET /v1/drugs/d1fb02dc-ab6d-4af0-9807-3c6f4dbae1b4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "15",
"substance": "HEXAPEPTIDE-12 (VAL-GLY-VAL-ALA-PRO-GLY)",
"productndc": "63083-7408",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "[hp_X]/59mL",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about hexapeptide-12 (val-gly-val-ala-pro-gly).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.